CHM Price sensitive 15 May 2025, 1:08 PM

ADVENT-AML Phase 1B clinical trial update

Chimeric Therapeutics Ltd

Sign in to open PDF

No summary is available for this announcement — sign in to read the PDF in full.

Sign in for more about this company, including guidance changes and other insights.
Sign in